Search research articles
Contact Us
Filters
Showing results (71-80 of 145) with videos related to
Page
of 15
Sort By:
Leukemia
|
July 31, 2023
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification
Michael J Hochman, Megan Othus, Robert P Hasserjian, et al.
Blood Advances
|
April 3, 2019
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab
Catherine Lai, Vishal Ranpura, Colin Wu, et al.
Experimental Hematology
|
October 22, 2013
Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events
Priyanka A Pophali, Jeffrey K Klotz, Sawa Ito, et al.
Leukemia
|
October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis
Nicholas J Short, Chenqi Fu, Donald A Berry, et al.
JAMA Oncology
|
October 8, 2020
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis
Nicholas J Short, Shouhao Zhou, Chenqi Fu, et al.
Blood Advances
|
March 23, 2021
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
Firas El Chaer, Uma Borate, Rémy Duléry, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 21, 2015
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation
Ankit Anand, Prathima Anandi, Natasha A Jain, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
Laura W Dillon, Jake Higgins, Hassan Nasif, et al.
Leukemia Research Reports
|
June 28, 2019
Rapid progression to AML in a patient with germline <i>GATA2</i> mutation and acquired <i>NRAS</i> Q61K mutation
Lisa J McReynolds, Yubo Zhang, Yanqin Yang, et al.
Haematologica
|
August 3, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
Laura W Dillon, Jake Higgins, Hassan Nasif, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 145) with videos related to
Sort By:
Page
of 15
Leukemia
|
July 31, 2023
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification
Michael J Hochman, Megan Othus, Robert P Hasserjian, et al.
Blood Advances
|
April 3, 2019
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab
Catherine Lai, Vishal Ranpura, Colin Wu, et al.
Experimental Hematology
|
October 22, 2013
Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events
Priyanka A Pophali, Jeffrey K Klotz, Sawa Ito, et al.
Leukemia
|
October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis
Nicholas J Short, Chenqi Fu, Donald A Berry, et al.
JAMA Oncology
|
October 8, 2020
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis
Nicholas J Short, Shouhao Zhou, Chenqi Fu, et al.
Blood Advances
|
March 23, 2021
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
Firas El Chaer, Uma Borate, Rémy Duléry, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 21, 2015
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation
Ankit Anand, Prathima Anandi, Natasha A Jain, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
Laura W Dillon, Jake Higgins, Hassan Nasif, et al.
Leukemia Research Reports
|
June 28, 2019
Rapid progression to AML in a patient with germline <i>GATA2</i> mutation and acquired <i>NRAS</i> Q61K mutation
Lisa J McReynolds, Yubo Zhang, Yanqin Yang, et al.
Haematologica
|
August 3, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
Laura W Dillon, Jake Higgins, Hassan Nasif, et al.
Page
of 15